VTN and neoplasm: Although a typical basement membrane matrix has not been described at the interface between xenograft tumor and host brain, reactive astrocytes (fibronectin), and the invading tumor itself (vitronectin, proteoglycans) can both secrete ECM components shared by the Matrigel® substrate [21,22].